L-23 p19 inhibitor - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

NTPC Limited has partnered with Africa50 to explore power generation projects and cross-border electricity trading across Africa, opening new opportunities for renewable energy investment, electricity infrastructure development and international expansion as India’s largest power company targets 149 GW of installed capacity by 2032. Representative image.

NTPC partners with Africa50 to develop African power projects as 149 GW ambition expands

Aegis Logistics Limited has agreed to acquire an 89.8% stake in Dubai-based Tristar Holdings Limited for approximately $809 million, marking a major expansion into global energy logistics, maritime fuel transportation, aviation fuelling and storage infrastructure across more than 30 countries. Representative image.

Aegis Logistics signs $809m Tristar acquisition to build global energy logistics business

Acronis protects 750,000 businesses. What does its new CEO need to change next?

Canada is getting its first pressboard manufacturing line. Why does Hitachi Energy need it now?

Read More

Pharma Industry News

Guselkumab meets primary endpoints in phase 3 psoriatic arthritis program

Johnson & Johnson’s Janssen Pharmaceutical said that its IL-23 p19 inhibitor TREMFYA (guselkumab) met the primary endpoints of…

bypharmanewsdaily

June 15, 2019

web analytics